Leukotriene modifiers for asthma treatment

Paolo Montuschi, M. L. Peters-Golden

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

86 Citazioni (Scopus)

Abstract

Leukotrienes (LTs), including cysteinyl LTs (CysLTs) and LTB(4) , are potent lipid mediators that have a role in the pathophysiology of asthma. At least two receptor subtypes for CysLTs, CysLT(1) and CysLT(2) , have been identified. The activation of the CysLT(1) receptor is responsible for most of the pathophysiological effects of CysLTs in asthma, including increased airway smooth muscle activity, microvascular permeability, and airway mucus secretion. LTB(4) might have a role in severe asthma, asthma exacerbations, and the development of airway hyperresponsiveness. CysLT(1) receptor antagonists can be given orally as monotherapy in patients with mild persistent asthma, but these drugs are generally less effective than inhaled glucocorticoids. Combination of CysLT(1) receptor antagonists and inhaled glucocorticoids in patients with more severe asthma may improve asthma control and enable the dose of inhaled glucocorticoids to be reduced while maintaining similar efficacy. The identification of subgroups of asthmatic patients who respond to CysLT(1) receptor antagonists is relevant for asthma management as the response to these drugs is variable. CysLT(1) receptor antagonists have a potential anti-remodelling effect that might be important for preventing or reversing airway structural changes in patients with asthma. This review discusses the role of LTs in asthma and the role of LT modifiers in asthma treatment.
Lingua originaleEnglish
pagine (da-a)1732-1741
Numero di pagine10
RivistaClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Volume40
Stato di pubblicazionePubblicato - 2010

Keywords

  • allergic airway disease
  • asthma
  • leukotriene receptor antagonists
  • leukotrienes
  • pharmacological treatment

Fingerprint Entra nei temi di ricerca di 'Leukotriene modifiers for asthma treatment'. Insieme formano una fingerprint unica.

Cita questo